CDK12-mutated prostate cancer: Clinical outcomes with standard therapies and immune checkpoint blockade JCO Precision Oncology 2019;3:382-392
Date
01/01/2019
DOI
10.1200/PO.19.00383Scopus ID
2-s2.0-85086473721 24 CitationsAuthor List
Schweizer MT, Ha G, Gulati R, Brown LC, McKay RR, Dorff T, Hoge ACH, Reichel J, Vats P, Kilari D, Patel V, Oh WK, Chinnaiyan A, Pritchard CC, Armstrong AJ, Montgomery RB, Alva A
Author
Deepak Kilari MD Associate Professor in the Medicine department at Medical College of Wisconsin